CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
暂无分享,去创建一个
W. Choi | J. Winter | K. Dybkær | M. Piris | Wei-min Liu | G. Bhagat | Y. Zu | K. Young | Z. Xu-Monette | L. Medeiros | K. Richards | M. Møller | J. Huh | G. Manyam | Li Zhang | S. Montes-Moreno | C. Visco | E. Hsi | M. Ponzoni | A. Ferreri | Yong Li | R. Miranda | A. Chiu | R. Go | W. Ai | A. Tzankov | J. H. Han van Krieken | Ling Li | A. Orazi | Shimin Hu | Xiaoying Zhao | Qin Huang | Lin Wu | A. Balasubramanyam | Mingzhi Zhang